[1] HULVAT M C. Cancer incidence and trends[J]. Surg Clin North Am, 2020, 100(3): 469-481. DOI: 10.1016/j.suc.2020.01.002. [2] WANG H, AN P, XIE E J, et al. Characterization of ferroptosis in murine models of hemochromatosis[J]. Hepatology, 2017, 66(2): 449-465. DOI: 10.1002/hep.29117. [3] ZHANG Y, SHI J J, LIU X G, et al. BAP1 links metabolic regulation of ferroptosis to tumour suppression[J]. Nat Cell Biol, 2018, 20(10): 1181-1192. DOI: 10.1038/s41556-018-0178-0. [4] 邱德文,杜江.中华本草·苗药卷[M].贵阳: 贵州科技出版社, 2005: 12, 21-22. [5] 国家医药管理局中草药情报中心站,植物药有效成分手册[M].北京: 人民卫生出版社, 1986:120-121. [6] 洪林,蒲兰,李冰冰,等.阔叶十大功劳的化学成分、药理作用及质量控制研究进展[J].贵州农业科学, 2019, 47(9): 122-125.DOI:10.3969/j.issn.1001-3601.2019.09.028. [7] 张业,邹碧群,方毅林,等.十大功劳果实提取物抗氧化活性研究[J].广西师范大学学报(自然科学版), 2011, 29(1): 43-46. DOI: 10.3969/j.issn.1001-6600.2011.01.010. [8] 蒋向辉,谭荣,杨永平,等.十大功劳甘草汤治疗肝炎的网络药理学研究[J].广西师范大学学报(自然科学版), 2021, 39(5): 198-209. DOI: 10.16088/j.issn.1001-6600.2020082201. [9] 侯丽艳,于成勇.一种治疗肝癌的中药: CN108096349A[P]. 2018-06-01. [10] ZHOU N, BAO J K.FerrDb: a manually curated resource for regulators and markers of ferroptosis and ferroptosis-disease associations[J]. Database, 2020, 2020:baaa021. DOI: 10.1093/database/baaa021. [11] CHANG Y-T, LIN Y-C, SUN L J, et al. Wilforine resensitizes multidrug resistant cancer cells via competitive inhibition of P-glycoprotein[J]. Phytomedicine, 2020, 71: 153239. DOI: 10.1016/j.phymed.2020.153239. [12] HU S S, CHEN S T, LI Z L, et al. Research on the potential mechanism of Chuanxiong Rhizoma on treating Diabetic Nephropathy based on network pharmacology[J]. Int J Med Sci, 2020, 17(15): 2240-2247. DOI: 10.7150/ijms.47555. [13] HOU G X, LIU P P, YANG J, et al. Mining expression and prognosis of topoisomerase isoforms in non-small-cell lung cancer by using Oncomine and Kaplan-Meier plotter[J]. PloS One, 2017, 12(3): e0174515. DOI: 10.1371/journal.pone.0174515. [14] CHANDRASHEKAR D S, BASHEL B, BALASUBRAMANYA S A H, et al. UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses[J]. Neoplasia, 2017, 19(8): 649-658. DOI: 10.1016/j.neo.2017.05.002. [15] LIU X Y, CHEN G N, DU G M, et al. Berbamine ameliorates ethanol-induced liver injury by inhibition of hepatic inflammation in mice[J]. Chinese Journal of Natural Medicines, 2020, 18(3): 186-195. DOI: 10.1016/S1875-5364(20)30020-0. [16] 赵凤娟,王琪,赵新华,等.抑郁介导肿瘤免疫微环境诱导肝癌不良预后研究[J].中国肿瘤, 2021, 30(3): 234-240. DOI: 10.11735/j.issn.1004-0242.2021.03.A008. [17] ZHANG Z Y, QIU X Y, YAN Y L, et al. Evaluation of Ferroptosis-related Gene AKR1C1 as a Novel Biomarker Associated with the Immune Microenvironment and Prognosis in Breast Cancer[J]. Int J Gen Med, 2021, 14: 6189-6200. DOI: 10.2147/IJGM.S329031. [18] PENNING T M. Aldo-Keto Reductase(AKR)1C3 inhibitors: a patent review[J]. Expert Opinion on Therapeutic Patents, 2017, 27(12): 1329-1340. DOI: 10.1080/13543776.2017.1379503. [19] DAUCH D, RUDALSKA R, COSSA G, et al. A MYC-aurora kinase A protein complex represents an actionable drug target in p53-altered liver cancer[J]. Nature Medicine, 2016, 22(7): 744-753. DOI: 10.1038/nm.4107. [20] GOOS J A C M, COUPÉ V M H, VAN DE WIEL M A, et al. A prognostic classifier for patients with colorectal cancer liver metastasis, based on AURKA, PTGS2 and MMP9[J]. Oncotarget, 2016, 7(2): 2123-2134. DOI: 10.18632/oncotarget.6188. [21] MIGNOGNA C, STAROPOLI N, BOTTA C, et al. Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patients[J]. Journal of Ovarian Research, 2016, 9(1): 31. DOI: 10.1186/s13048-016-0238-7. [22] JIN X H, WANG J B, ZOU S, et al. Cinobufagin triggers defects in spindle formation and cap-dependent translation in liver cancer cells by inhibiting the AURKA-mTOR-eIF4E Axis[J]. The American Journal of Chinese Medicine, 2020, 48(3): 651-678. DOI: 10.1142/S0192415X20500330. [23] LIN C, HU R F, SUN F F, et al. Ferroptosis-based molecular prognostic model for adrenocortical carcinoma based on least absolute shrinkage and selection operator regression[J]. J Clin Lab Anal, 2022, 36(6): e24465. DOI: 10.1002/jcla.24465. [24] YUN D B, WANG X Y, WANG W B, et al. A novel prognostic signature based on glioma essential ferroptosis-related genes predicts clinical outcomes and indicates treatment in Glioma[J]. Front Oncol, 2022, 12: 897702. DOI: 10.3389/fonc.2022.897702. ( |